Central Texas Medical Center offers innovative new procedure for dissolving blood clots
SAN MARCOS, TEXAS
– Central Texas Medical Center (CTMC) today announced that the facility will be the first in the region to offer the EKOS® Acoustic Pulse Thombolysis™ procedure, a life-saving technique that dissolves blood clots in the vascular system via a catheter. The EKOS® procedure is minimally invasive, uses lower doses of medicine and is used to treat conditions including pulmonary embolism, deep vein thrombosis (DVT) and peripheral arterial occlusion. The hospital expects to begin using the procedure in April.
During catheter-assisted thrombolysis treatment, a catheter is guided through blood vessels to the location of the blood clot. The catheter will deliver special clot dissolving medicine called thrombolytics to help dissolve the clot. EKOS also delivers ultrasound energy to mechanically dislodge and loosen the clot. The EKOS® procedure increases thrombus (blood clot) removal and clinical improvement compared to either standard catheter-directed thrombolysis (CDT) or thrombectomy. Additional benefits include:
• Speeds time-to-dissolution
• Lowers the risk of bleeding and other complications
• Provides more effective drug delivery and superior thrombus clearance
• Reduced procedure time
“Implementing the EKOS procedure is the latest example of how CTMC continues to be at the forefront of heart-related services in our region,” said Anthony Stahl, Chief Executive Officer at CTMC. “With this new technology, we are able to lower patient risk while achieving higher procedure predictability. Our team is committed to improving patient outcomes, and procedures like these help us achieve that mission.”
For more information about EKOS® Acoustic Pulse Thombolysis™, visit ekoscorp.com/learningcenter.htm or visit their booth at the CTMC HealthCheck event on April 12 at Embassy Suites Hotel, Spa & Conference Center in San Marcos.
The 170-bed hospital, which originated in 1923 as Hays County Soldiers, Sailors and Marines Memorial Hospital, opened at its current Wonder World Drive location in 1983. The CTMC staff of more than 700 employees works with more than 220 active and consulting physicians to provide quality services to patients and their families. CTMC is the only hospital between San Antonio and Austin to be recognized with an “A” safety score by the independent Leapfrog Group. In addition to interventional cardiac services, CTMC is a Certified Chest Pain Center and an accredited Primary Stroke Center. CTMC leads the region in da Vinci robotic-assisted surgery and offers a variety of specialty care services including medical imaging, rehabilitation, home health care, hospice, women’s services and more. For more information, follow CTMC on Facebook, Twitter, Pinterest and on YouTube. Visit our website at ctmc.org.
CTMC is a member of the Adventist Health System (AHS), a not-for-profit healthcare organization that emphasizes Christ at the center of care. Founded in 1973, Adventist Health System is a national leader in quality, safety and patient satisfaction. Today, Adventist Health System supports 45 campuses in 10 states and employs nearly 70,000 individuals. Adventist Health System hospitals are comprised of nearly 8,300 licensed beds, providing care for 4.5 million patients each year in inpatient, outpatient and emergency room visits.About EKOS®
EKOS® Corporation, a BTG International group company, pioneered the development and clinical application of ultrasound infusion technologies in medicine. It introduced its first system for the treatment of vascular thrombosis (blood clots) in 2005.
Since its beginning, EKOS® has had one goal: develop life-enhancing and lifesaving treatments for blood clots that occur in arteries and veins. Our endovascular therapies improve patient outcomes, lower risks and improve treatment predictability.
Today, interventional radiologists, cardiologists, vascular and cardiothoracic surgeons at leading institutions around the world use the EKOS® EkoSonic® Endovascular System to provide faster, safer and more complete dissolution of thrombus.